Publications

Export 2430 results:
Sort by: [ Author  (Asc)] Title Type Year
A B C D E F G [H] I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
el-Din, H. M., M. A. Attia, M. R. Hamza, H. M. Khaled, M. A. Thoraya, and S. A. Eisa, "Hepatitis C Virus and related changes in immunological parameters in non Hodgkin's lymphoma patients.", Egypt J Immunol, vol. 11, no. 1, pp. 55-64, 2004. AbstractWebsite

{Viral hepatitis is a common and important problem in immunocompromised cancer patients. The present study was conducted to investigate changes in some cellular and humoral immunological parameters as a consequence of HCV infection in non Hodgkin's lymphoma patients (NHL). The study included 40 NHL patients: 20 anti-HCV antibody positive (Gr. I ), and 20 anti-HCV antibody negative (Gr.II ). In addition, forty non-cancer controls (NCCs) were included: 20 of them were anti-HCV antibody positive (Gr. III) and 20 anti-HCV antibody negative (Gr. IV). The studied immunological parameters included serum levels of interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6), and soluble tumor necrosis factor receptors (s-TNFr) measured by ELISA, as well as assessment of T and B lymphocyte subsets by PAP immunostaining method. Mean IL-1 level (pg/ml) was significantly higher in Gr. 1 (14 +/- 6) and Gr. III (20 +/- 12) as compared to those in Gr. II (7 +/- 5) and Gr. IV (9 +/- 6). Mean IL-2 level (pg/ml) was also significantly higher in Gr. I (132 +/- 101) and Gr. III (135 +/- 59) compared to those in Gr. II (36 +/- 29) and Gr. IV (31 +/- 48). On the other hand, level of IL-6 showed no significant difference between groups. The mean level of sTNF-r, (ng/ml) was only significantly higher in Gr. I (2.9 +/- 1.7) when compared to that in Gr. IV (1.9 +/- 2.2). In group IV, the average percentage of CD3 (70 +/- 4%) and CD4 (44 +/- 5%) were significantly higher than in those of Gr. I (CD3 = 51 +/- 11%

sherine abdelmissihfatma abd elhalim ebtissam abd elghaffar olfat shaker amira labib, magdy ishak, "How Rolipram, as a Phosphodiesterase-4 Inhibitor, Affects Acute Isoniazid-Induced Seizures and Pentylenetetrazole Kindling in Rats", Med. J. Cairo Univ., Vol. 83, vol. vol 83, issue No. 2 , pp. 373-384, 2015.
el-Magied, M. A. M., E. M. Hassan, and M. A. T. El-Akel, "High protein cookies made with pigeon pea and sorghum blends", J. Agric. Res. & Dev.,(March)., vol. 13, no. I, 1991. Abstract
n/a
el-Din, H. M., M. A. Attia, M. R. Hamza, H. M. Khaled, M. A. Thoraya, and S. A. Eisa, "Hepatitis C Virus and related changes in immunological parameters in non Hodgkin's lymphoma patients.", Egypt J Immunol, vol. 11, no. 1, pp. 55-64, 2004. AbstractWebsite

{Viral hepatitis is a common and important problem in immunocompromised cancer patients. The present study was conducted to investigate changes in some cellular and humoral immunological parameters as a consequence of HCV infection in non Hodgkin's lymphoma patients (NHL). The study included 40 NHL patients: 20 anti-HCV antibody positive (Gr. I ), and 20 anti-HCV antibody negative (Gr.II ). In addition, forty non-cancer controls (NCCs) were included: 20 of them were anti-HCV antibody positive (Gr. III) and 20 anti-HCV antibody negative (Gr. IV). The studied immunological parameters included serum levels of interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6), and soluble tumor necrosis factor receptors (s-TNFr) measured by ELISA, as well as assessment of T and B lymphocyte subsets by PAP immunostaining method. Mean IL-1 level (pg/ml) was significantly higher in Gr. 1 (14 +/- 6) and Gr. III (20 +/- 12) as compared to those in Gr. II (7 +/- 5) and Gr. IV (9 +/- 6). Mean IL-2 level (pg/ml) was also significantly higher in Gr. I (132 +/- 101) and Gr. III (135 +/- 59) compared to those in Gr. II (36 +/- 29) and Gr. IV (31 +/- 48). On the other hand, level of IL-6 showed no significant difference between groups. The mean level of sTNF-r, (ng/ml) was only significantly higher in Gr. I (2.9 +/- 1.7) when compared to that in Gr. IV (1.9 +/- 2.2). In group IV, the average percentage of CD3 (70 +/- 4%) and CD4 (44 +/- 5%) were significantly higher than in those of Gr. I (CD3 = 51 +/- 11%

.
.Afifi, N. A., E. H. S.M, F. M.M., and S. O.A., "Hypoglycemic activity of certain Egyptian plants containing mucilage and / or pectin.", Bull. Fac. Pharm. Cairo Univ., , vol. 34(3):, pp. 189-202, 1996.
1
1- Ahmad A. Al Sallab, Hossam Fahmy, M. R., "Hardware Implementation of Distributed Speech Recognition Front End", 17th European Signal Processing Conference - EUSIPCO 2009, 2009. Abstract
n/a
4
46. ZA El-Gendy, A Ramadan, S. A. E. - B. R. F. A. S. A. E. - M. S. A. E. - R. S. A. H. Y. S., "Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats", Heliyon, vol. 7, issue 6, 2021. saccharomyces_cervisciae__1-s2.0-s2405844021012627-main.pdf
A
A, Y., S. M, E. G, A. - S. M, O. A, D. W, O. D, S. Y, K. S, A. - B. A, et al., "HLA tissue typing has no effect on the outcome of patients undergoing a living-donor liver transplant: a single-center experience in Egypt.", Experimental and clinical transplantation, vol. 10, issue 2, pp. 136-40, 2012. Abstracthla_2012.pdf

OBJECTIVES:
To analyze the effect of human leukocyte antigen tissue typing on outcome of live-donor liver transplant.
MATERIALS AND METHODS:
Fifty recipients underwent live-donor liver transplant in the Dar Al-Fouad Hospital in Egypt and were retrospectively evaluated. Patients were classified into 2 groups: those with human leukocyte antigen +ve, and those with human leukocyte antigen -ve and donors. Hepatitis C virus-related end-stage liver disease was the main indication for transplant. Demographic data, preoperative laboratory data, results of human leukocyte antigen tissue typing, Child score, model for end-stage liver disease score, graft/recipient weight-ratio, ischemia times, surgical complications, postoperative laboratory data, liver biopsy, immunosuppression, and pulse steroids were collected. Graft and patient survivals were studied using Kaplan-Meier curves.
RESULTS:
The mean model end-stage liver disease score was 18 ± 3.61 in group 1 and 17.73 ± 3.72 in group 2, with no significant difference. Graft/recipient weight ratio, ischemia times, and postoperative complications showed P = NS. Cyclosporine and tacrolimus were used in 5/9, 8/41, and 4/9 in group 1, and 32/41 in group 2 (P = NS). Rejection and pulse steroids were reported in 3/9 and 12/41 of group 1, and 3/12 and 11/41 of group 2 (P = NS). Hepatitis C virus-recurrence was diagnosed in 5/9 of patients (55%) and 8/41 of patients (29.5%) in groups 1 and 2 (P < .05). No statistical difference was found regarding mortality; 5-year patient and graft survival was 35/50 (70% in group 1 [human leukocyte antigen +ve]), 7/9 (77.8%), and 28/41 in group 2 (68.3%) (human leukocyte antigen -ve).
CONCLUSIONS:
Positive human leukocyte antigen typing before live-donor liver transplant has no effect on the incidence of postoperative complications, rejection episodes, and patient or graft survival. Recipients with positive human leukocyte antigen typing may have increased risk of hepatitis C virus-recurrence after live-donor liver transplant.

A, M., E. - T. O, S. AA, S. D, R. L, and M. A, "Homing and efficacy of Intra-articular Injection of Autologous Mesenchymal Stem Cells in Experimental Chondral Defects in Dogs", Clinical and experimental Rheumatology 29(2):275-284, vol. 29, issue 2, pp. 275-284, 2011. stem_cell_in_dogs_homing.pdf
A, A., F. S, Y. A, Dalia Negm Eldin, and ebeid e, "HEPATOBLASTOMA IN A DEVELOPING COUNTRY: OUTCOME AND PROGNOSTIC FACTORS", Pediatric Blood & Cancer, vol. 66, issue 1, 2019.
A, V. K., S. G. E, S. D, S. C, S. YP, Zhang T, V. K. TH, H. C, K. EO, P. MS, et al., "HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression.", Int J Cancer., vol. 135, issue 11, pp. 2579-92, 2014.
A., E. M., M. El-Husseiny, and S. Kassem, "High Performance Balanced Flow Modulating Hydraulic Control Valves", Proceedings of IMCE 2016 International Mechanical Engineering Congress and Exposition , Phoenix, AZ, US, November 11-17, , 2016.
A., S. M., N. A. Afifi, E. - B. H. A., and Shimaa I. Ramadan, "Hepatoprotective and antioxidant effects of Marjorana hortensis plant in CCL4- intoxicated rats", Natural Products of Indian Journal, vol. accepted for puplication, 2013.
A., A. E. M., and H. Osman A, "The histopathological damage in donkey's stomach due to infestation of Gastrophilus intestinalis", Egypt. J. Biomed. Sci. , vol. 14, pp. 366-376, 2004.
A. M. Negm, F. M. Abdelrazek, M. H. Elnagdi, and L.H.Shaaban, "Heterocyclic synthesis with nitriles: New routes for synthesis of Pyridazines, pyridines and their fused derivatives.", Arch. Pharmacal Res., vol. 17, issue 6, pp. 411-417, 1994.
A. S. Shawali, A. A. O., A. O. Abdelhamid, and H. M. Hassneen, "Hydrolysis of N3, N3-Disubstituted Amidrazones: Syntheis of Oxanilic Arylhydrazides", Indian J. Chem., vol. 10, pp. 965 , 1972.
A.A, S., S. H.A, Z. M, and E. S.H, "Hypoglycemic and Hypolipidemic actions of Vanadyl acetylacetonate and Nigella sativa in streptozotocin induced diabetic rats", Egyptian Journal of basic And Applied Physiology, vol. 15, issue No.1, pp. 23-45, 2015.
A.Afifi, N., E. H. S.M., F. M.M., and S. O.A., "Hypoglycemic activity of certain Egyptian plants containing mucilage and / or pectin.", Bull. Fac. Pharm. Cairo Univ.,, vol. 34(3), pp. 189- 202, 1996.
A.Badr, "Hybrid Training of Feedforward Neural Networks: Genetic Algorithms plus Backpropagation", Annual Conference on Statistics, pp. 17-19, 1994.
A.H, A., H. D. M. Soad M. Nasr 2, H. Soufy, A. M. Soliman, S. A. Nassar, A. A. Maweri, T. A. H. El-Aziz, and H. M. Desouky, "Hepatoprotective and antioxidant effects of methanol extractof Moringa oleifera leaves in rats", Wulfenia J., vol. 24, issue 3, pp. 249-268, Submitted.
A.hedya, S., M. M.Safar, and Ashraf K. Bahgat, "Hydroxychloroquine antiparkinsonian potential: Nurr1 modulation versus autophagy inhibition.", Behavioral Brain research, pp. 82-88, 2019.
A.L.Aboul-Nasr, "Hysteroscopic endometrial ablation. ", Middle East Fertil Soc. J. , vol. 2, issue 3, pp. 185-194, 1997.
A.L.Aboul-Nasr, N.A.Abdel-Kader, E.Fateen, and R.A.Ezzat, "HELLP syndrome in severe preeclampsia/ Eclampsia.", Med. J. Cairo Univ., vol. 61, issue 2, pp. 351-358, 1993.